Dunvegan Associates’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$12K Hold
300
– – 0.01% 154
2015
Q3
$12K Hold
300
– – 0.01% 155
2015
Q2
$11K Hold
300
– – 0.01% 155
2015
Q1
$10K Hold
300
– – 0.01% 169
2014
Q4
$8K Hold
300
– – 0.01% 176
2014
Q3
$7K Hold
300
– – 0.01% 174
2014
Q2
$8K Hold
300
– – 0.01% 169
2014
Q1
$6K Buy
+300
New +$6.47K 0.01% 191

Other funds holding HOLX

Dunvegan Associates's HOLX Position: Q4 2015 in Review

Dunvegan Associates held its Hologic (HOLX) position steady in Q4 2015 at 300 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #154.

Dunvegan Associates first reported a position in HOLX in Q1 2014 and has held it in 8 quarters since. 451 funds tracked by Wall St. Rank hold HOLX as of Q4 2015.

  • Dunvegan Associates held 300 shares of Hologic worth $12K as of Q4 2015.
  • Dunvegan Associates left its Hologic share count unchanged in Q4 2015.
  • Hologic made up 0.01% of Dunvegan Associates's portfolio in Q4 2015, its #154 holding.
  • Dunvegan Associates first reported a position in Hologic in Q1 2014 and has held it in 8 quarters since.
  • 451 funds tracked by Wall St. Rank held Hologic as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.